The effect of amiodarone loading (1400 mg/day for 7 days) and maintenance therapy (400 mg/day) on the signal-averaged electrocardiogram (SAECG) and the QTc were evaluated in 14 patients. Daily recordings were taken for the first 7 days of loading and on the ninth, twelfth, fourteenth, and twenty-first day of maintenance therapy. All patients had inducible sustained ventricular tachycardia (VT), 10 of them had late potential (LP) positive recording, and four were LP negative during control measurements. Amiodarone loading significantly changed all SAECG indices and prolonged the QTc. Changes induced by amiodarone were present within 24 hours of administration. The time to reach peak effect varied from 6 to 9 days. The maximum increase in late potential duration (LPD) was threefold greater than the increase in filtered QRS duration or QTc (61% vs 18% vs 14%, respectively), suggesting a more pronounced effect on the reentrant pathway than on the remaining myocardium. Of the four LP negative patients, three became LP positive while receiving amiodarone. In conclusion, amiodarone affects all SAECG indices. However, the magnitude of the changes varies, being most pronounced on the LPD. Amiodarone affects the SAECG and the QTc within the first 24 hours. The time of onset of the peak effect varies from 6 to 9 days. LP negative patients with inducible VT frequently became LP positive during amiodarone therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0002-8703(88)90009-9DOI Listing

Publication Analysis

Top Keywords

amiodarone loading
12
maintenance therapy
8
saecg qtc
8
patients inducible
8
late potential
8
saecg indices
8
negative patients
8
amiodarone saecg
8
amiodarone
7
qtc
5

Similar Publications

Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

View Article and Find Full Text PDF

Importance: Over 10 000 people with Chagas disease experience sudden cardiac death (SCD) annually, mostly caused by ventricular fibrillation. Amiodarone hydrochloride and the implantable cardioverter-defibrillator (ICD) have been empirically used to prevent SCD in patients with chronic Chagas cardiomyopathy.

Objective: To test the hypothesis that ICD is more effective than amiodarone therapy for primary prevention of all-cause mortality in patients with chronic Chagas cardiomyopathy and moderate to high mortality risk, assessed by the Rassi score.

View Article and Find Full Text PDF
Article Synopsis
  • Postoperative atrial fibrillation (POAF) can lead to serious complications like stroke and death, and a rhythm-control strategy is generally better than rate control for stable patients.
  • This study aimed to assess if a higher loading dose of intravenous amiodarone could more effectively restore normal heart rhythm in patients experiencing POAF following noncardiac surgery.
  • Results showed that patients receiving the higher amiodarone dosage restored sinus rhythm faster (about 2.4 hours) compared to those on the standard dosage (around 8.7 hours), though both groups achieved similar results by the 24-hour mark.
View Article and Find Full Text PDF

Amiodarone is commonly used nowadays for the treatment of atrial fibrillation (AF). The wide use of this medication has led to the occurrence of adverse events, including pulmonary toxicity, hepatotoxicity, thyroid dysfunction, and many others. Higher doses of Amiodarone of ≥400 mg/day have been linked to increased complications.

View Article and Find Full Text PDF

Designing Microneedle Patch for Prophylaxis of Postoperative Atrial Fibrillation.

ACS Nano

July 2024

Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.

Postoperative atrial fibrillation (POAF) is a common complication following cardiac surgery, which often occurs within 30 postoperative days, especially peaking at 2-3 days. Antiarrhythmic medications such as amiodarone are recommended in clinical practice for the prophylaxis and treatment of POAF. However, conventional oral administration is hindered due to delayed drug action and high risks of systemic toxicity, and emerging localized delivery strategies suffer from a limited release duration (less than 30 days).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!